Manipulating dietary carbohydrates to treat irritable bowel syndrome

Clinical Insights: Irritable Bowel Syndrome: Diagnosis and Management

Volumn , Issue , 2013, Pages 81-103

  Muir, Jane G ^b   Gibson, Peter R ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957102120     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2217/EBO.13.493     Document Type: Chapter

References (26)

1. Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am. J. Gastroenterol. 107(5), 657-666 (2012).
2. Cummings JH, Stephen AM. Carbohydrate terminology and classification. Eur. J. Clin. Nutr. 61(Suppl. 1), S5-S18 (2007).
3. Bird AR, Conlon MA, Christophersen CT, Topping DL. Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef. Microbes 1(4), 423-431 (2010).
4. Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol. Ther. 25(4), 349-363 (2007).
5. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J. Gastroenterol. Hepatol. 25(2), 252-258 (2010).
6. Roberfroid MB. Inulin-type fructans: functional food ingredients. J. Nutr. 137(Suppl. 11), S2493-S2502 (2007).
7. Sangwan V, Tomar SK, Singh RR, Singh AK, Ali B. Galactooligosaccharides: novel components of designer foods. J. Food Sci. 76(4), R103-R111 (2011).
8. Lomer MC, Parkes GC, Sanderson JD. Review article: lactose intolerance in clinical practice - myths and realities. Aliment Pharmacol. Ther. 27(2), 93-103 (2008).
9. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol. Ther. 30(2), 165-174 (2009).
10. Livesey G. Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr. Res. Rev. 16, 163-191 (2003).
11. Macfarlane GT, Macfarlane S. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J. Clin. Gastroenterol. (Suppl. 45), S120-S127 (2011).
12. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol. Ther. 27(2), 104-119 (2008).
13. Potty VH. Physio-chemical aspects, physiological functions, nutritional importance and technological significance of dietary fibers - a critical review. J. Food Sic. Tech. 33(1), 1-18 (1996).
14. Elia M, Cummings JH. Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates. Eur. J. Clin. Nutr. 61(Suppl. 1), S40-S74 (2007).
15. Roberfroid M, Gibson GR, Hoyles L et al. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 104(Suppl. 2), S1-S63 (2010).
16. Ford AC, Talley NJ, Spiegel BM et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. Br. Med. J. 337, a2313 (2008).
17. Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst. Rev. 8, CD003460 (2011).
18. Quigley EM. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol. Clin. North Am. 40(1), 207-222 (2011).
19. Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am. J. Clin. Nutr. 72, 1570-1575 (2000).
20. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J. Am. Diet. Assoc. 106, 1631-1639 (2006).
21. de Roest RH, Dobbs BR, Chapman BA et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int. J. Clin. Pract. 67, 895-903 (2013).
22. Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin. Gastroenterol. Hepatol. 6, 765-771 (2008).
23. Ong DK, Mitchell SBM, Barrett JS et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J. Gastroenterol. Hepatol. 25, 1366-1373 (2010).
24. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome: a randomized controlled cross-over trial. Gastroenterology (2013) (In Press).
25. Staudacher HM, Whelan K, Irving PM, Lomer MCE. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J. Hum. Nutr. Diet 24, 487-495 (2010).
26. Staudacher HM, Lomer MC, Anderson JL et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J. Nutr. 142(8), 1510-1518 (2012).